Clinical verification of the activity and tolerability of fitostimoline vaginal pessaries in women with hysterectomy : randomized, perspective, monoscentric study
Articolo
Data di Pubblicazione:
2022
Citazione:
Clinical verification of the activity and tolerability of fitostimoline vaginal pessaries in women with hysterectomy : randomized, perspective, monoscentric study / M. Grandinetti, L. Nazzaro, R. Izzo, M. Vignali. - In: OBSTETRICS AND GYNECOLOGY: OPEN ACCESS. - ISSN 2577-2236. - 6:1(2022 Jan 28), pp. 143.1-143.7. [10.29011/2577-2236.100143]
Abstract:
Objective: To evaluate the activity of Fitostimoline® pessaries in comparison to the standard of care in the treatment of women with hysterectomy. Methods: An observational, randomized, perspective study performed on 60 women where 30 women were treated with Fitostimoline® pessaries for 12 days after surgery and 30 women were treated with the standard of care. A first follow-up visit was performed at 12 +/- 3 days and a final follow- up visit was performed at 40 +/- 3 days.
Results: At the first control, 45% of patients in the Fitostimoline® group reported no evidence of vaginal bleeding after surgery; instead, 41% in the control group reported such result. At the final visit, 79% patients reported no evidence of vaginal bleeding in the Fitostimoline® group, while 63% in the control group. The medial duration of minor vaginal bleeding in the Fitostimoline® group was 11.8 days, whilst for discrete vaginal bleeding the medial duration was 4 days. In the control group instead it was 12 days, whilst for discrete vaginal bleeding the medial duration was 8 days.
Conclusion: The use of Fitostimoline® ovules after hysterectomy is effective in reducing the quantity of vaginal bleeding, regardless the menopausal status, surgical approach and type of indication to surgery.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
hysterectomy; fitostimoline® pessaries; vaginal bleeding
Elenco autori:
M. Grandinetti, L. Nazzaro, R. Izzo, M. Vignali
Link alla scheda completa: